Abstract:
The invention is a hard capsule comprising pullulan in an amount of 85% to 90% by weight, potassium chloride in an amount of 1.0% to 1.5% by weight, carrageenan in an amount of 0.1% to 0.4% by weight, one or more surfactants in an amount of 0.1% to 0.2% by weight and water in an amount of 10% to 15% by weight. Additionally the invention is related to new uses of pullulan containing containers.
Abstract:
The invention is directed to providing a communication interface in a network appliance that enables a software update for the network appliance to be securely and wirelessly provided by a mobile node over a relatively limited (short) distance with a mobile node. The operator of the mobile node is authenticated and communication between the network appliance and the mobile node is encrypted. Even if an unauthorized person was able to be positioned in relatively close proximity to a network appliance such as within the physical confines of a data center, these authentication and encryption measures make it difficult for an unauthorized update to be provided to the network appliance. Updating the software for a network appliance can include one or more actions including, but not limited to, deleting existing files, rebooting, uploading new files, such as binaries, scripts, JAVA applications, and the like.
Abstract:
A process for encapsulation of caplets in a capsule comprises the following steps: a. providing empty capsule parts; b. filling at least one of said capsule parts with one or more caplets; c. putting said capsule parts together; and d. treating the combined parts by cold shrinking. The solid dosage forms obtainable by such aprocess are tamper-proof in that they cannot be opened in a way to be reassembled without showing such opening process.
Abstract:
A particular object of the invention is to provide a telescope-type capsule, e.g., for pharmaceutical use or the like, consisting of a cap and a body, the cap having four to six elongated, flat protrusions on its inner wall with a depth of from 30 to 100 .mu.m, preferably 50 to 80 .mu.m, and a length of 1.5 to 3 mm, and a narrowing positioned between the closed end and cylindrically shaped part of the capsule. The narrowing has an area with smaller inclination relative to the capsule axis and an area with stronger inclination which is disposed further away from the open end of the cap than the area with smaller inclination and has a width of 2 to 3 mm and an inclination of 0.03 to 0.07 mm/mm, preferably 0.04 to 0.06 mm/mm. A locking ring with a depth of from 30 to 160 .mu.m, preferably 140 to 120 .mu.m and a width of from 0.8 to 1.2 mm is provided on said narrowing. The body comprises likewise a locking ring, the counter locking ring, which matches the locking ring of the cap and has a depth of 25 to 70 .mu.m and a width of 0.7 to 1.3 mm. Furthermore, at its open end the body is provided with an area of reduced diameter formed by a circular shaped ring with a depth of 10 to 60 .mu.m and a width of 0.8 to 1.4 mm and a wider ring of symmetrical or asymmetrical cross-sectional profile to fit the elongated protrusions.